Evidence map›Paper›PMID 33513208›Full record

ArticlePLoS pathogens2021

Human FcRn expression and Type I Interferon signaling control Echovirus 11 pathogenesis in mice.

Alexandra I Wells, Kalena A Grimes, Kenneth Kim, Emilie Branche, Christopher J Bakkenist, William H DePas, Sujan Shresta, Carolyn B Coyne

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Cardiomyocyte β-arrestins mediate inflammation and cGAS-STING activation in CVB3 viral myocarditis.American journal of physiology. Heart and circulatory physiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Pathoimmunological analyses of fatal E11 infection in premature infants.Frontiers in cellular and infection microbiology · 2024
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alexandra I WellsDepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.ORCID 0000-0001-8178-0376
Kalena A GrimesDepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Kenneth KimKord Animal Health Diagnostic Laboratory, Nashville, Tennessee, United States of America.ORCID 0000-0002-5993-4575
Emilie BrancheCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology La Jolla, California, United States of America.ORCID 0000-0002-1687-7355
Christopher J BakkenistDepartment of Radiation Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
William H DePasDepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.ORCID 0000-0001-8532-2567
Sujan ShrestaCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology La Jolla, California, United States of America.ORCID 0000-0003-2906-8474
Carolyn B CoyneDepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.ORCID 0000-0002-1884-6309
University of Pittsburgh · USLa Jolla Institute for Immunology · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
Immunology of Infectious DiseaseT32AI060525 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JoAnne L. Flynn · 2005 to 2026
$5.3M
Enterovirus Infection of Polarized Intestinal CellsR01AI081759 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI COYNE, CAROLYN B · 2009 to 2024
$5.0M
The Role of FcRn in Echovirus Entry and PathogenesisR01AI150151 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI COYNE, CAROLYN B · 2020 to 2024
$2.4M
Enterovirus Infection of Polarized Intestinal CellsR56AI081759 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI COYNE, CAROLYN B · 2013 to 2019
$749k
Defining the Role of the Neonatal Fc Receptor in a Novel Model of Echovirus II InfectionF31AI149866 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WELLS, ALEXANDRA · 2020 to 2021
$79k
NCI NIH HHS P30 CA047904NIAID NIH HHS F31 AI149866NIAID NIH HHS R01 AI081759NIAID NIH HHS R01 AI150151NIAID NIH HHS R56 AI081759NIAID NIH HHS T32 AI060525
6 · The paper itself

Abstract

Neonatal echovirus infections are characterized by severe hepatitis and neurological complications that can be fatal. Here, we show that expression of the human homologue of the neonatal Fc receptor (hFcRn), the primary receptor for echoviruses, and ablation of type I interferon (IFN) signaling are key host determinants involved in echovirus pathogenesis. We show that expression of hFcRn alone is insufficient to confer susceptibility to echovirus infections in mice. However, expression of hFcRn in mice deficient in type I interferon (IFN) signaling, hFcRn-IFNAR-/-, recapitulate the echovirus pathogenesis observed in humans. Luminex-based multianalyte profiling from E11 infected hFcRn-IFNAR-/- mice revealed a robust systemic immune response to infection, including the induction of type I IFNs. Furthermore, similar to the severe hepatitis observed in humans, E11 infection in hFcRn-IFNAR-/- mice caused profound liver damage. Our findings define the host factors involved in echovirus pathogenesis and establish in vivo models that recapitulate echovirus disease in humans.

Indexed as

Signal TransductionAnimalsEnterovirus B, HumanEnterovirus InfectionsFemaleGene ExpressionGenome, ViralHepatitisHepatocytesHistocompatibility Antigens Class IHumansImmunityInterferon Type ILiverMaleMiceFc receptor, neonatalHistocompatibility Antigens Class IInterferon Type IReceptors, Fc

Identifiers

PMID33513208
PMCPMC7875378
OpenAlexW3123047429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.